This protocol is judged by an institutional assessment board, an impartial team that reviews any clinical trials involving humans. If a review will involve a Program I drug, when the board approves the protocol as ethical, the scientists really need to submit an application for an investigational new drug (IND) quantity with the FDA.And Because the